Clinic Regulation and Responsibility — Transparency of Products, Practitioners, and Treatment Records

The aesthetic market is growing faster than clients’ ability to understand the information available. A service may be advertised by device name, product name, number of millilitres, or number of shots, while more important information is absent: who performs the service, where the product comes from, which area it is used for, and how the clinic responds if there is a problem.

International regulators are increasing warnings about unapproved fillers, needle-free injection devices, botulinum toxin sold through unlawful sources, and products marketed beyond the available safety data. Although specific regulations differ between countries, the overall direction is clear: invasive aesthetic services need to be managed as activities with risks, not as ordinary consumer goods.

• Disclosing the product name is not only for sales

For filler, botulinum toxin, skinbooster, or other injectable products, clients need to know the trade name, manufacturer, expected amount, and intended objective.

Saying only “Korean product,” “European product,” or “VIP type” is not enough. These terms do not allow traceability if a reaction occurs, and they do not show whether the product is being used for the correct indication.

The clinic should keep photos of the box, batch number, expiry date, and amount used in the record.

• The practitioner needs to be introduced with the correct role

Titles build trust, but they must not be used in a way that misleads clients. A person who performs treatment, laser, or PMU needs to state their role and scope of work accurately.

If a service requires a licensed person or medical expertise under local regulations, the clinic must comply. Marketing content cannot replace legal requirements.

For DIVA, the title “Founder & Treatment Practitioner” is more appropriate than calling oneself a doctor without corresponding verification.

• Records before and after treatment protect both clients and the clinic

Records are not only for storing before-and-after images. They should include the initial condition, history, current products, method, settings or product amount, immediate reactions after treatment, and the instructions given.

When clients return or move to another method, this data helps prevent duplicate treatment, assess reactions, and support evidence-based decisions.

For a solo clinic, the system does not need to be complex from the beginning. A fixed form, dated images, and clear notes are better than relying entirely on memory or chat history.

• Consent is not a liability-waiver document

A client’s agreement to treatment after an explanation does not mean the clinic is exempt from responsibility if the process is wrong. Consent has value when clients receive understandable information about the objective, limitations, common reactions, significant risks, and alternatives.

A long list of technical terms should not simply be handed over for the client to sign quickly. The important points need to be explained in language the client understands.

• Advertising needs to separate expected outcomes from promises

Terms such as “100%,” “permanent,” “painless,” “no downtime,” and “absolutely safe” can generate messages but also create expectations that cannot be controlled.

Aesthetic outcomes depend on the condition, technique, product, and care. Content should use language such as “may support,” “results vary,” and “an in-person assessment is needed,” and should clearly state when an image shows the result of multiple sessions or combined methods.

• Supply source and storage chain are part of safety

A genuine product can still lose quality if it is transported or stored incorrectly. Botulinum toxin and many biological products require specific conditions.

The clinic needs a process for receiving goods and checking packaging, temperature, batch number, and expiry date. A suspicious product should not be used simply because it has already been paid for.

• A referral process needs to be prepared in advance

Not every reaction can be managed at the clinic. Difficulty breathing, difficulty swallowing, changes in vision, severe pain, unusual skin discolouration, fever, or signs of infection require referral to a medical facility.

The clinic should prepare the address, contact number, and instructions in advance rather than beginning to search only after an incident occurs.

DIVA’s Perspective

DIVA is building a website and an AI system, but technology has value only when the underlying data is clear. Price lists, guidance, product names, contraindications, and escalation procedures need to be managed as official data.

AI should not independently choose a laser, promise results, or answer beyond its scope. When a question involves complications, medication, pregnancy, underlying conditions, or an invasive decision, the system needs to refer it to the responsible person.

Conclusion

The direction of aesthetic regulation is toward greater transparency: clear products, clear practitioners, clear records, and clear advertising limits.

For a solo clinic, this is not an administrative burden. A good record system reduces repetitive consultation, protects treatment outcomes, and builds more sustainable trust than any discount programme.

Reference: FDA Dermal Fillers, FDA-Approved Dermal Fillers, and the 2025 FDA warning concerning unlawfully marketed botulinum toxin. This article does not replace legal advice in Cambodia.